Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Gynecomastia Treatment Market

ID: MRFR/HC/19118-HCR
128 Pages
Vikita Thakur
Last Updated: April 06, 2026

Gynecomastia Treatment Market Research Report Information By Type (Drugs and Surgical Treatment), By Application (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Gynecomastia Treatment Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Healthcare, BY Type (USD Billion)
  49.     4.1.1 Drugs
  50.     4.1.2 Surgical Treatment
  51.   4.2 Healthcare, BY Application (USD Billion)
  52.     4.2.1 Hospital Pharmacies
  53.     4.2.2 Retail Pharmacies
  54.     4.2.3 Online Pharmacies
  55.   4.3 Healthcare, BY Region (USD Billion)
  56.     4.3.1 North America
  57.       4.3.1.1 US
  58.       4.3.1.2 Canada
  59.     4.3.2 Europe
  60.       4.3.2.1 Germany
  61.       4.3.2.2 UK
  62.       4.3.2.3 France
  63.       4.3.2.4 Russia
  64.       4.3.2.5 Italy
  65.       4.3.2.6 Spain
  66.       4.3.2.7 Rest of Europe
  67.     4.3.3 APAC
  68.       4.3.3.1 China
  69.       4.3.3.2 India
  70.       4.3.3.3 Japan
  71.       4.3.3.4 South Korea
  72.       4.3.3.5 Malaysia
  73.       4.3.3.6 Thailand
  74.       4.3.3.7 Indonesia
  75.       4.3.3.8 Rest of APAC
  76.     4.3.4 South America
  77.       4.3.4.1 Brazil
  78.       4.3.4.2 Mexico
  79.       4.3.4.3 Argentina
  80.       4.3.4.4 Rest of South America
  81.     4.3.5 MEA
  82.       4.3.5.1 GCC Countries
  83.       4.3.5.2 South Africa
  84.       4.3.5.3 Rest of MEA
  85. 5 SECTION V: COMPETITIVE ANALYSIS
  86.   5.1 Competitive Landscape
  87.     5.1.1 Overview
  88.     5.1.2 Competitive Analysis
  89.     5.1.3 Market share Analysis
  90.     5.1.4 Major Growth Strategy in the Healthcare
  91.     5.1.5 Competitive Benchmarking
  92.     5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  93.     5.1.7 Key developments and growth strategies
  94.       5.1.7.1 New Product Launch/Service Deployment
  95.       5.1.7.2 Merger & Acquisitions
  96.       5.1.7.3 Joint Ventures
  97.     5.1.8 Major Players Financial Matrix
  98.       5.1.8.1 Sales and Operating Income
  99.       5.1.8.2 Major Players R&D Expenditure. 2023
  100.   5.2 Company Profiles
  101.     5.2.1 Johnson & Johnson (US)
  102.       5.2.1.1 Financial Overview
  103.       5.2.1.2 Products Offered
  104.       5.2.1.3 Key Developments
  105.       5.2.1.4 SWOT Analysis
  106.       5.2.1.5 Key Strategies
  107.     5.2.2 AbbVie Inc. (US)
  108.       5.2.2.1 Financial Overview
  109.       5.2.2.2 Products Offered
  110.       5.2.2.3 Key Developments
  111.       5.2.2.4 SWOT Analysis
  112.       5.2.2.5 Key Strategies
  113.     5.2.3 Bausch Health Companies Inc. (CA)
  114.       5.2.3.1 Financial Overview
  115.       5.2.3.2 Products Offered
  116.       5.2.3.3 Key Developments
  117.       5.2.3.4 SWOT Analysis
  118.       5.2.3.5 Key Strategies
  119.     5.2.4 Medytox Inc. (KR)
  120.       5.2.4.1 Financial Overview
  121.       5.2.4.2 Products Offered
  122.       5.2.4.3 Key Developments
  123.       5.2.4.4 SWOT Analysis
  124.       5.2.4.5 Key Strategies
  125.     5.2.5 Revance Therapeutics Inc. (US)
  126.       5.2.5.1 Financial Overview
  127.       5.2.5.2 Products Offered
  128.       5.2.5.3 Key Developments
  129.       5.2.5.4 SWOT Analysis
  130.       5.2.5.5 Key Strategies
  131.     5.2.6 Galderma S.A. (CH)
  132.       5.2.6.1 Financial Overview
  133.       5.2.6.2 Products Offered
  134.       5.2.6.3 Key Developments
  135.       5.2.6.4 SWOT Analysis
  136.       5.2.6.5 Key Strategies
  137.     5.2.7 Ipsen S.A. (FR)
  138.       5.2.7.1 Financial Overview
  139.       5.2.7.2 Products Offered
  140.       5.2.7.3 Key Developments
  141.       5.2.7.4 SWOT Analysis
  142.       5.2.7.5 Key Strategies
  143.     5.2.8 Hugel, Inc. (KR)
  144.       5.2.8.1 Financial Overview
  145.       5.2.8.2 Products Offered
  146.       5.2.8.3 Key Developments
  147.       5.2.8.4 SWOT Analysis
  148.       5.2.8.5 Key Strategies
  149.     5.2.9 Sientra, Inc. (US)
  150.       5.2.9.1 Financial Overview
  151.       5.2.9.2 Products Offered
  152.       5.2.9.3 Key Developments
  153.       5.2.9.4 SWOT Analysis
  154.       5.2.9.5 Key Strategies
  155.   5.3 Appendix
  156.     5.3.1 References
  157.     5.3.2 Related Reports
  158. 6 LIST OF FIGURES
  159.   6.1 MARKET SYNOPSIS
  160.   6.2 NORTH AMERICA MARKET ANALYSIS
  161.   6.3 US MARKET ANALYSIS BY TYPE
  162.   6.4 US MARKET ANALYSIS BY APPLICATION
  163.   6.5 CANADA MARKET ANALYSIS BY TYPE
  164.   6.6 CANADA MARKET ANALYSIS BY APPLICATION
  165.   6.7 EUROPE MARKET ANALYSIS
  166.   6.8 GERMANY MARKET ANALYSIS BY TYPE
  167.   6.9 GERMANY MARKET ANALYSIS BY APPLICATION
  168.   6.10 UK MARKET ANALYSIS BY TYPE
  169.   6.11 UK MARKET ANALYSIS BY APPLICATION
  170.   6.12 FRANCE MARKET ANALYSIS BY TYPE
  171.   6.13 FRANCE MARKET ANALYSIS BY APPLICATION
  172.   6.14 RUSSIA MARKET ANALYSIS BY TYPE
  173.   6.15 RUSSIA MARKET ANALYSIS BY APPLICATION
  174.   6.16 ITALY MARKET ANALYSIS BY TYPE
  175.   6.17 ITALY MARKET ANALYSIS BY APPLICATION
  176.   6.18 SPAIN MARKET ANALYSIS BY TYPE
  177.   6.19 SPAIN MARKET ANALYSIS BY APPLICATION
  178.   6.20 REST OF EUROPE MARKET ANALYSIS BY TYPE
  179.   6.21 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
  180.   6.22 APAC MARKET ANALYSIS
  181.   6.23 CHINA MARKET ANALYSIS BY TYPE
  182.   6.24 CHINA MARKET ANALYSIS BY APPLICATION
  183.   6.25 INDIA MARKET ANALYSIS BY TYPE
  184.   6.26 INDIA MARKET ANALYSIS BY APPLICATION
  185.   6.27 JAPAN MARKET ANALYSIS BY TYPE
  186.   6.28 JAPAN MARKET ANALYSIS BY APPLICATION
  187.   6.29 SOUTH KOREA MARKET ANALYSIS BY TYPE
  188.   6.30 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
  189.   6.31 MALAYSIA MARKET ANALYSIS BY TYPE
  190.   6.32 MALAYSIA MARKET ANALYSIS BY APPLICATION
  191.   6.33 THAILAND MARKET ANALYSIS BY TYPE
  192.   6.34 THAILAND MARKET ANALYSIS BY APPLICATION
  193.   6.35 INDONESIA MARKET ANALYSIS BY TYPE
  194.   6.36 INDONESIA MARKET ANALYSIS BY APPLICATION
  195.   6.37 REST OF APAC MARKET ANALYSIS BY TYPE
  196.   6.38 REST OF APAC MARKET ANALYSIS BY APPLICATION
  197.   6.39 SOUTH AMERICA MARKET ANALYSIS
  198.   6.40 BRAZIL MARKET ANALYSIS BY TYPE
  199.   6.41 BRAZIL MARKET ANALYSIS BY APPLICATION
  200.   6.42 MEXICO MARKET ANALYSIS BY TYPE
  201.   6.43 MEXICO MARKET ANALYSIS BY APPLICATION
  202.   6.44 ARGENTINA MARKET ANALYSIS BY TYPE
  203.   6.45 ARGENTINA MARKET ANALYSIS BY APPLICATION
  204.   6.46 REST OF SOUTH AMERICA MARKET ANALYSIS BY TYPE
  205.   6.47 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
  206.   6.48 MEA MARKET ANALYSIS
  207.   6.49 GCC COUNTRIES MARKET ANALYSIS BY TYPE
  208.   6.50 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
  209.   6.51 SOUTH AFRICA MARKET ANALYSIS BY TYPE
  210.   6.52 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
  211.   6.53 REST OF MEA MARKET ANALYSIS BY TYPE
  212.   6.54 REST OF MEA MARKET ANALYSIS BY APPLICATION
  213.   6.55 KEY BUYING CRITERIA OF HEALTHCARE
  214.   6.56 RESEARCH PROCESS OF MRFR
  215.   6.57 DRO ANALYSIS OF HEALTHCARE
  216.   6.58 DRIVERS IMPACT ANALYSIS: HEALTHCARE
  217.   6.59 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
  218.   6.60 SUPPLY / VALUE CHAIN: HEALTHCARE
  219.   6.61 HEALTHCARE, BY TYPE, 2024 (% SHARE)
  220.   6.62 HEALTHCARE, BY TYPE, 2024 TO 2035 (USD Billion)
  221.   6.63 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
  222.   6.64 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
  223.   6.65 BENCHMARKING OF MAJOR COMPETITORS
  224. 7 LIST OF TABLES
  225.   7.1 LIST OF ASSUMPTIONS
  226.     7.1.1
  227.   7.2 North America MARKET SIZE ESTIMATES; FORECAST
  228.     7.2.1 BY TYPE, 2025-2035 (USD Billion)
  229.     7.2.2 BY APPLICATION, 2025-2035 (USD Billion)
  230.   7.3 US MARKET SIZE ESTIMATES; FORECAST
  231.     7.3.1 BY TYPE, 2025-2035 (USD Billion)
  232.     7.3.2 BY APPLICATION, 2025-2035 (USD Billion)
  233.   7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  234.     7.4.1 BY TYPE, 2025-2035 (USD Billion)
  235.     7.4.2 BY APPLICATION, 2025-2035 (USD Billion)
  236.   7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  237.     7.5.1 BY TYPE, 2025-2035 (USD Billion)
  238.     7.5.2 BY APPLICATION, 2025-2035 (USD Billion)
  239.   7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  240.     7.6.1 BY TYPE, 2025-2035 (USD Billion)
  241.     7.6.2 BY APPLICATION, 2025-2035 (USD Billion)
  242.   7.7 UK MARKET SIZE ESTIMATES; FORECAST
  243.     7.7.1 BY TYPE, 2025-2035 (USD Billion)
  244.     7.7.2 BY APPLICATION, 2025-2035 (USD Billion)
  245.   7.8 France MARKET SIZE ESTIMATES; FORECAST
  246.     7.8.1 BY TYPE, 2025-2035 (USD Billion)
  247.     7.8.2 BY APPLICATION, 2025-2035 (USD Billion)
  248.   7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  249.     7.9.1 BY TYPE, 2025-2035 (USD Billion)
  250.     7.9.2 BY APPLICATION, 2025-2035 (USD Billion)
  251.   7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  252.     7.10.1 BY TYPE, 2025-2035 (USD Billion)
  253.     7.10.2 BY APPLICATION, 2025-2035 (USD Billion)
  254.   7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  255.     7.11.1 BY TYPE, 2025-2035 (USD Billion)
  256.     7.11.2 BY APPLICATION, 2025-2035 (USD Billion)
  257.   7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  258.     7.12.1 BY TYPE, 2025-2035 (USD Billion)
  259.     7.12.2 BY APPLICATION, 2025-2035 (USD Billion)
  260.   7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  261.     7.13.1 BY TYPE, 2025-2035 (USD Billion)
  262.     7.13.2 BY APPLICATION, 2025-2035 (USD Billion)
  263.   7.14 China MARKET SIZE ESTIMATES; FORECAST
  264.     7.14.1 BY TYPE, 2025-2035 (USD Billion)
  265.     7.14.2 BY APPLICATION, 2025-2035 (USD Billion)
  266.   7.15 India MARKET SIZE ESTIMATES; FORECAST
  267.     7.15.1 BY TYPE, 2025-2035 (USD Billion)
  268.     7.15.2 BY APPLICATION, 2025-2035 (USD Billion)
  269.   7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  270.     7.16.1 BY TYPE, 2025-2035 (USD Billion)
  271.     7.16.2 BY APPLICATION, 2025-2035 (USD Billion)
  272.   7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  273.     7.17.1 BY TYPE, 2025-2035 (USD Billion)
  274.     7.17.2 BY APPLICATION, 2025-2035 (USD Billion)
  275.   7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  276.     7.18.1 BY TYPE, 2025-2035 (USD Billion)
  277.     7.18.2 BY APPLICATION, 2025-2035 (USD Billion)
  278.   7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  279.     7.19.1 BY TYPE, 2025-2035 (USD Billion)
  280.     7.19.2 BY APPLICATION, 2025-2035 (USD Billion)
  281.   7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  282.     7.20.1 BY TYPE, 2025-2035 (USD Billion)
  283.     7.20.2 BY APPLICATION, 2025-2035 (USD Billion)
  284.   7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  285.     7.21.1 BY TYPE, 2025-2035 (USD Billion)
  286.     7.21.2 BY APPLICATION, 2025-2035 (USD Billion)
  287.   7.22 South America MARKET SIZE ESTIMATES; FORECAST
  288.     7.22.1 BY TYPE, 2025-2035 (USD Billion)
  289.     7.22.2 BY APPLICATION, 2025-2035 (USD Billion)
  290.   7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  291.     7.23.1 BY TYPE, 2025-2035 (USD Billion)
  292.     7.23.2 BY APPLICATION, 2025-2035 (USD Billion)
  293.   7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  294.     7.24.1 BY TYPE, 2025-2035 (USD Billion)
  295.     7.24.2 BY APPLICATION, 2025-2035 (USD Billion)
  296.   7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  297.     7.25.1 BY TYPE, 2025-2035 (USD Billion)
  298.     7.25.2 BY APPLICATION, 2025-2035 (USD Billion)
  299.   7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  300.     7.26.1 BY TYPE, 2025-2035 (USD Billion)
  301.     7.26.2 BY APPLICATION, 2025-2035 (USD Billion)
  302.   7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  303.     7.27.1 BY TYPE, 2025-2035 (USD Billion)
  304.     7.27.2 BY APPLICATION, 2025-2035 (USD Billion)
  305.   7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  306.     7.28.1 BY TYPE, 2025-2035 (USD Billion)
  307.     7.28.2 BY APPLICATION, 2025-2035 (USD Billion)
  308.   7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  309.     7.29.1 BY TYPE, 2025-2035 (USD Billion)
  310.     7.29.2 BY APPLICATION, 2025-2035 (USD Billion)
  311.   7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  312.     7.30.1 BY TYPE, 2025-2035 (USD Billion)
  313.     7.30.2 BY APPLICATION, 2025-2035 (USD Billion)
  314.   7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  315.     7.31.1
  316.   7.32 ACQUISITION/PARTNERSHIP
  317.     7.32.1

Healthcare Market Segmentation

Healthcare By Type (USD Billion, 2025-2035)

  • Drugs
  • Surgical Treatment

Healthcare By Application (USD Billion, 2025-2035)

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions